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Introduction
The Na + :HCO 3 -contransporter NBC1 mediated bicarbonate transport and is located on the basolateral membrane of kidney proximal tubule and a number of other epithelia including pancreatic duct, gastric parietal cells, small intestine, and pulmonary alveolar cells (1) (2) (3) (4) (5) (6) . NBC1 functions in tandem with apical Na + /H + exchanger 3 (NHE3) and is essential for bicarbonate reabsorption in kidney proximal tubule (4, 7, 8) . In pancreas, NBC1 is responsible for bicarbonate transport into pancreatic duct for eventual secretion into the pancreatic duct (4, 9, 10) . Two well known variants of NBC1 are expressed in various epithelial tissues. These are the kidney (kNBC1) and pancreatic (pNBC1)
variants, which differ only in their N-terminal sequence, where amino acids 1 to 41 in kNBC1 has been replaced with 85 amino acids in pNBC1 (3) . The carboxyl terminal end of NBC1 is identical in kidney and pancreatic variants (1) (2) (3) . Kidney NBC1 has a stoichiometry of 3 equivalent of bicarbonate for each sodium whereas pancreatic NBC1 has a stochiometry of 2 equivalents of bicarbonate per each sodium (11, 12) . This alteration in stochiometry allows for the kidney NBC1 to function in the absorptive mode and for the pancreatic NBC1 to function in the secretory mode (4, (9) (10) (11) (12) .
In all tissues examined to date NBC1 is found to be located on the basolateral membrane of epithelial cells (4-6) strongly suggesting the presence of specific amino acid motif(s) that direct its targeting to the basolateral membrane. To identify possible motifs that are responsible for the targeting of NBC1 to the basolateral membrane, various Cterminally truncated NBC1 mutants were generated, fused translationally in-frame to GFP and transiently expressed in cultured kidney epithelial cells. The results demonstrate
Methods and Material.
Construction of GFP-NBC1 full length and mutants. The full length and various Cterminally truncated NBC1 mutants were generated by PCR, using the human full length NBC1 DNA (3257bp and 1035 a.a residues) as a template (AF007216). The truncated NBC1 proteins have C-terminal deletions of 3, 20, 26, or 50 amino acid residues and are designated as NBC1 CD3, CD20, CD26, or CD50, respectively. The resulting wild type and various C-terminally truncated NBC1 mutants were amplified and fused translationally in-frame to GFP by cloning into pcDNA3.1/NT-GFP-TOPO vector (Invitrogen, Carlsbad, California).
Full length kNBC1 was amplified using the following primers: t986730: 5' GAATTCGAGATGGCACTGAAAATGTGGAAGGG (sense) and t968120: 5'
AGCGGCCGCCTCAGCATGATGTGTGGCGTTCAAGGAATGT (antisense). These primers were used to generate full length NBC1 cDNA from PCI-NEO NBC1 plasmid (1) . This resulted in the expression of GFP-NBC1 fusion protein with the GFP fusing to the N-terminus of kNBC1 (GFP-NBC1). Using a similar approach, primer 1 (sense, above) and primer 3 (t80925:
5'GCGGCCGCTCAGTGGCGTTCAAGGAATGTTGGTGA (antisense), were used to generate the NBC1-CD3 cDNA. This resulted in the expression of the GFP-NBC1 fusion protein, which coded the truncated NBC1 (CD3), with deletion of the last 3 amino acid residues on the carboxyl terminal end. For CD20, CD26, and CD50 (deletion of the last 20, 26, and 50 amino acid residues, respectively) the following (antisense) primers were used : CD20 3'  primer:  5'  GCGGCCGCTCAGCAGCTTAGGAA   AGGTTGCTGTTCCATGATGTCCATTGGAAT3';  CD26  3'  primer---5' GCGGCCGCTCAGCAGCTTAGGAAAGGTTGCTATTCCATGATGTCCATTGGAA   T3'; and CD50 3' primer---5'TCAGTC ACTGTCCAGACTTCCCTTCTT3 '. In separate experiments we also generated NBC1 CD67 construct (67 amino acid deletion) using 3' primer : 5' CTATTTCTTGTCCTTTTCTGGAATGAC3'. For the last series of experiments we generated NBC1 CD23 construct (23 amino acid deletion) using 3'
primer : 5' GCGGCCGCTCAAGGTTGCTGTTCCATGATGTCCATTGGAAT 3'. The sense primer in all mutants was the same as in full length NBC1 (above).
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Functional expression of full length GFP-NBC1 and GFP-NBC1 mutants in oocytes.
Stage IV-V oocytes were isolated as previously described and used for expression studies according to established methods (15 To determine whether further truncation of the carboxyl terminal end affects its membrane localization, NBC1 mutants with 50 amino acid residues deletion were generated, coupled to GFP and transiently expressed in MDCK cells. In the next series of experiments we examined the functional activity of NBC1-GFP CD26 mutant in oocytes by membrane potential measurement (1, 2, 14) . For comparison, oocytes injected with GFP-NBC1 full length or GFP only (no NBC insert) cRNA were utilized. We were specifically interested in NBC1-CD26, as this is the mutant with the shortest truncation, which shows mistargeting to the apical membrane (Fig. 4) . As demonstrated ( Fig. 7 (panel B) , the F1013A mutation caused the retargeting of NBC1 to the apical membrane.
Discussion
The targeting of NBC1 to the basolateral membrane was examined using a series of mutants with progressive truncation of the carboxyl terminal end that were fused in frame to GFP and visualized by confocal microscope. The results demonstrated that the full length NBC1 and mutants with up to 20 amino acid deletion from the carboxyl terminal end are targeted to the basolateral membrane (Figs. 1-3) . However, the NBC1 mutant with 26 amino acids deletion from its C-terminal end showed mistargeting to the apical membrane domain, with some labeling observed on the basolateral membrane (Fig. 4) .
Additional truncations for up to 67 amino acid residues showed persistence of labeling on NBC1 is located basolaterally in various epithelia and mediates vectroial transport of bicarbonate. In kidney, NBC1 is located on the basolateral membrane of proximal tubules and mediates the exit of bicarbonate from cell to blood (4-6, 17, 18). In pancreas, NBC1
is located on the basolateral membrane of ducts and mediates the entry of bicarbonate from blood to cell (4-6, 19, 20) . Studies on NBC1 have demonstrated that the kidney variant (kNBC1) has a stoichiometry of 3 equivalent of bicarbonate per sodium whereas the pancreatic variant (pNBC1) has a stoichiometry of 2 bicarbonate per sodium (11, 12) .
The difference in the stoichiometry allows for the change in the direction of NBC1 movement from absorptive (i.e. in kidney) to secretory (i.e. in pancreatic duct).
The most salient feature of the current study is the identification of a carboxyl The apically targeted NBC1 is functionally active (Fig. 6 
